Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHF Research FoundationHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Mar 2 2022 | US FDA approves Jardiance® (empagliflozin) to treat adults with heart failure regardless of left ventricular ejection fraction Industry News In The News Industry Read More Mar 1 2022 | Heart Failure Collaboratory (HFC)/HFSA Joint Site-Based Research Awards Call for 2022 Nominations Practice News Annual Scientific Meeting Awards Research Read More Feb 28 2022 | Cytokinetics announces start of SEQUOIA-HCM, a phase 3 clinical trial of aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy Industry News Industry Read More Feb 28 2022 | Cytokinetics announces topline results from METEORIC-HF Industry News Industry Read More Feb 28 2022 | Renovacor Announces Partnerships with the Dilated Cardiomyopathy Foundation, the Heart Failure Society of America and the American Association of Heart Failure Nurses to Help Increase Awareness of Genetic Heart Disorders Industry News Industry Read More Pagination First page « First Previous page ‹ Previous … Page 40 Page 41 Page 42 Page 43 Current page 44 Page 45 Page 46 Page 47 Page 48 … Next page Next › Last page Last »
Mar 2 2022 | US FDA approves Jardiance® (empagliflozin) to treat adults with heart failure regardless of left ventricular ejection fraction Industry News In The News Industry Read More
Mar 1 2022 | Heart Failure Collaboratory (HFC)/HFSA Joint Site-Based Research Awards Call for 2022 Nominations Practice News Annual Scientific Meeting Awards Research Read More
Feb 28 2022 | Cytokinetics announces start of SEQUOIA-HCM, a phase 3 clinical trial of aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy Industry News Industry Read More
Feb 28 2022 | Cytokinetics announces topline results from METEORIC-HF Industry News Industry Read More
Feb 28 2022 | Renovacor Announces Partnerships with the Dilated Cardiomyopathy Foundation, the Heart Failure Society of America and the American Association of Heart Failure Nurses to Help Increase Awareness of Genetic Heart Disorders Industry News Industry Read More
